Terms: = Pancreatic cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1
804 results:
1. Strategies to Perform Emergency Laparoscopic Partial Liver Resection for Ruptured Hepatocellular Carcinoma.
Tsunematsu M; Onda S; Shirai Y; Abe K; Horiuchi T; Haruki K; Furukawa K; Okui N; Taniai T; Ikegami T
Anticancer Res; 2024 May; 44(5):2171-2176. PubMed ID: 38677754
[TBL] [Abstract] [Full Text] [Related]
2. The pancreatic cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals.
Zogopoulos G; Haimi I; Sanoba SA; Everett JN; Wang Y; Katona BW; Farrell JJ; Grossberg AJ; Paiella S; Klute KA; Bi Y; Wallace MB; Kwon RS; Stoffel EM; Wadlow RC; Sussman DA; Merchant NB; Permuth JB; Golan T; Raitses-Gurevich M; Lowy AM; Liau J; Jeter JM; Lindberg JM; Chung DC; Earl J; Brentnall TA; Schrader KA; Kaul V; Huang C; Chandarana H; Smerdon C; Graff JJ; Kastrinos F; Kupfer SS; Lucas AL; Sears RC; Brand RE; Parmigiani G; Simeone DM;
J Natl Compr Canc Netw; 2024 Apr; 22(3):158-166. PubMed ID: 38626807
[TBL] [Abstract] [Full Text] [Related]
3. Assessment of disease control rate and safety of sorafenib in targeted therapy for advanced liver cancer.
Zeng D; Yu C; Chen S; Zou L; Chen J; Xu L
World J Surg Oncol; 2024 Apr; 22(1):93. PubMed ID: 38605359
[TBL] [Abstract] [Full Text] [Related]
4. Polycyclic Aromatic Hydrocarbons and pancreatic cancer: An Analysis of the Blood Biomarker,
Nguyen S; Carlson H; Yoder A; Bamlet WR; Oberg AL; Petersen GM; Carmella SG; Hecht SS; Jansen RJ
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474816
[TBL] [Abstract] [Full Text] [Related]
5. The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in pancreatic Adenocarcinoma Cells Applied Danusertib.
Alabaş E; Ata Özçimen A
Turk J Gastroenterol; 2024 Feb; 35(2):150-157. PubMed ID: 38454247
[TBL] [Abstract] [Full Text] [Related]
6. Laparoscopic radical antegrade modular pancreatosplenectomy (RAMPS) for adenocarcinoma of the body and tail of the pancreas - technical considerations with analysis of surgical outcomes.
Borys M; Wysocki M; Gałązka K; Stanek M; Budzyński A
Langenbecks Arch Surg; 2024 Feb; 409(1):74. PubMed ID: 38400929
[TBL] [Abstract] [Full Text] [Related]
7. cancer burden and risk in the Chinese population aged 55 years and above: A systematic analysis and comparison with the USA and Western Europe.
Gao TY; Tao YT; Li HY; Liu X; Ma YT; Li HJ; Xian-Yu CY; Deng NJ; Leng WD; Luo J; Zhang C
J Glob Health; 2024 Jan; 14():04014. PubMed ID: 38271210
[TBL] [Abstract] [Full Text] [Related]
8. Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer.
Kashiro A; Kobayashi M; Oh T; Miyamoto M; Atsumi J; Nagashima K; Takeuchi K; Nara S; Hijioka S; Morizane C; Kikuchi S; Kato S; Kato K; Ochiai H; Obata D; Shizume Y; Konishi H; Nomura Y; Matsuyama K; Xie C; Wong C; Huang Y; Jung G; Srivastava S; Kutsumi H; Honda K
J Gastroenterol; 2024 Mar; 59(3):263-278. PubMed ID: 38261000
[TBL] [Abstract] [Full Text] [Related]
9. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.
Labori KJ; Bratlie SO; Andersson B; Angelsen JH; Biörserud C; Björnsson B; Bringeland EA; Elander N; Garresori H; Grønbech JE; Haux J; Hemmingsson O; Liljefors MG; Myklebust TÅ; Nymo LS; Peltola K; Pfeiffer P; Sallinen V; Sandström P; Sparrelid E; Stenvold H; Søreide K; Tingstedt B; Verbeke C; Öhlund D; Klint L; Dueland S; Lassen K;
Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):205-217. PubMed ID: 38237621
[TBL] [Abstract] [Full Text] [Related]
10. Long-term outcomes after surgical resection of pancreatic metastases from renal Clear-cell carcinoma.
Boubaddi M; Marichez A; Adam JP; Chiche L; Laurent C
Eur J Surg Oncol; 2024 Feb; 50(2):107960. PubMed ID: 38219701
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic significance of occult vertebral fracture in patients undergoing pancreatic resection for pancreatic cancer.
Ishizaki S; Furukawa K; Haruki K; Tsunematsu M; Shirai Y; Matsumoto M; Okui N; Onda S; Taniai T; Ikegami T
Pancreatology; 2024 Mar; 24(2):249-254. PubMed ID: 38218681
[TBL] [Abstract] [Full Text] [Related]
12. Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study.
Kai M; Hikita H; Kazuki M; Tahata Y; Shinkai K; Doi A; Ohkawa K; Miyazaki M; Ishida H; Matsumoto K; Nozaki Y; Yakushijin T; Sakamori R; Kaneko A; Iio S; Nawa T; Kakita N; Morishita N; Hiramatsu N; Usui T; Imanaka K; Doi Y; Sakakibara M; Yoshida Y; Oze T; Kodama T; Tatsumi T; Takehara T
PLoS One; 2024; 19(1):e0294590. PubMed ID: 38165900
[TBL] [Abstract] [Full Text] [Related]
13. Short- and long-term outcomes of robotic versus open radical antegrade modular pancreatosplenectomy: a retrospective propensity score-matched cohort study.
Song Y; Zou W; Gao Y; Zhao Z; Yin Z; Xiao C; Liu Q; Liu R
Surg Endosc; 2024 Mar; 38(3):1316-1328. PubMed ID: 38110793
[TBL] [Abstract] [Full Text] [Related]
14. The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors.
Zeng ZX; Wu JY; Wu JY; Li YN; Fu YK; Zhang ZB; Liu DY; Li H; Ou XY; Zhuang SW; Yan ML
Hepatol Int; 2024 Apr; 18(2):651-660. PubMed ID: 38040945
[TBL] [Abstract] [Full Text] [Related]
15. Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial.
Melisi D; Zecchetto C; Merz V; Malleo G; Landoni L; Quinzii A; Casalino S; Fazzini F; Gaule M; Pesoni C; Casetti L; Esposito A; Marchegiani G; Piazzola C; D'Onofrio M; de Robertis R; Gabbrielli A; Bernardoni L; Crino SF; Pietrobono S; Luchini C; Aliberti C; Martignoni G; Milleri S; Butturini G; Scarpa A; Salvia R; Bassi C
Eur J Cancer; 2024 Jan; 196():113430. PubMed ID: 37995598
[TBL] [Abstract] [Full Text] [Related]
16. Incorporation of protein induced by vitamin K absence or antagonist-II into transplant criteria expands beneficiaries of liver transplantation for hepatocellular carcinoma: a multicenter retrospective cohort study in China.
Wang K; Dong L; Lu Q; Yang Z; Fan X; Gao F; Ge W; Wang Z; Zhou Z; Lu D; Wei X; Wei Q; Zhuang L; Qin L; Ye Q; Yang J; Dong J; Zheng S; Xu X
Int J Surg; 2023 Dec; 109(12):4135-4144. PubMed ID: 37988413
[TBL] [Abstract] [Full Text] [Related]
17. Short-term and long-term outcomes after robotic versus open hepatectomy in patients with large hepatocellular carcinoma: a multicenter study.
Zhang XP; Jiang N; Zhu L; Lin ZY; Guo WX; Chen X; Ma YT; Zhang F; Tang YF; Chen ZL; Yan ML; Zhao ZM; Li CG; Lau WY; Cheng SQ; Hu MG; Liu R
Int J Surg; 2024 Feb; 110(2):660-667. PubMed ID: 37983785
[TBL] [Abstract] [Full Text] [Related]
18. Preoperative assessment of peripheral vascular invasion of pancreatic ductal adenocarcinoma based on high-resolution MRI.
Zhou X; Xu D; Wang M; Ma R; Song C; Dong Z; Luo Y; Wang J; Feng ST
BMC Cancer; 2023 Nov; 23(1):1092. PubMed ID: 37950223
[TBL] [Abstract] [Full Text] [Related]
19. Application of single-layer continuous duct-to-mucosa pancreaticojejunostomy with two figure-of-eight sutures in total laparoscopic pancreaticoduodenectomy.
Li D; Du C; Zhao W; Li S; Lv H; Wang W
Langenbecks Arch Surg; 2023 Nov; 408(1):434. PubMed ID: 37949977
[TBL] [Abstract] [Full Text] [Related]
20. Utilization of muscle area in an accurate prediction formula for renal function for patients with hepatocellular carcinoma.
Hayashi H; Shimizu A; Kubota K; Kitagawa N; Notake T; Masuo H; Yoshizawa T; Sakai H; Yasukawa K; Soejima Y
Asian J Surg; 2024 Feb; 47(2):893-898. PubMed ID: 37923599
[TBL] [Abstract] [Full Text] [Related]
[Next]
